Brain Scientific Inc.
BRSF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $124 | $12,227 | $10,388 | $12,888 |
| - Cash | $748 | $2,030 | $3,543 | $346 |
| + Debt | $2,863 | $2,077 | $1,618 | $11,749 |
| Enterprise Value | $2,240 | $12,274 | $8,463 | $24,290 |
| Revenue | $5 | $11 | $38 | $160 |
| % Growth | -55.6% | -70.3% | -75.9% | – |
| Gross Profit | -$6 | $7 | $0 | $53 |
| % Margin | -127.1% | 64.5% | 1.3% | 33.2% |
| EBITDA | -$103 | -$4,086 | -$698 | -$1,704 |
| % Margin | -2,031% | -35,739.3% | -1,815.4% | -1,067.6% |
| Net Income | -$3,948 | -$4,153 | -$1,221 | -$2,160 |
| % Margin | -77,714.6% | -36,323.8% | -3,173.6% | -1,353.5% |
| EPS Diluted | -3.18 | -3.35 | -1.7 | -3.63 |
| % Growth | 5.1% | -97.1% | 53.2% | – |
| Operating Cash Flow | -$1,243 | -$1,420 | -$1,778 | -$1,494 |
| Capital Expenditures | -$6 | -$20 | -$1 | -$7 |
| Free Cash Flow | -$1,249 | -$1,440 | -$1,779 | -$1,500 |